US$ 29.64
abbvie glp-1 plans to build out its presence in obesity market endorsed procedures abbvie glp-1 receptor agonist weight
Description
This does not influence our rankings or medical evaluations
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
(NYSE: PFE)

10.1056/NEJMoa1612917 36 HolstJ

Clancy, T

The specific sites of action and underlying molecular mechanisms that mediate GLP-1R-induced body weight loss are currently being investigated
